{{Drugbox
| Verifiedfields = 
| Watchedfields = 
| verifiedrevid = 
| IUPAC_name = 2-[4-[(3''Z'')-3-(2-chloro-6''H''-benzo[''c''][1]benzoxepin-11-ylidene)propyl]piperazin-1-yl]ethanol
| image = 
| width = 

<!--Clinical data-->
| tradename = 
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category = 
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = 
| legal_UK = 
| legal_US = 
| legal_status = 
| routes_of_administration = [[Oral administration|Oral]]

<!--Pharmacokinetic data-->
| bioavailability = 
| protein_bound = 
| metabolism = 
| elimination_half-life = 
| excretion = 

<!-- Identifiers -->
| CAS_number_Ref = 
| CAS_number = 14008-66-3
| CAS_supplemental = <br />14008-46-9 ([[hydrochloride]])
| class = 
| ATC_prefix = 
| ATC_suffix = 
| ATC_supplemental = 
| PubChem = 6436541
| IUPHAR_ligand = 
| DrugBank_Ref = 
| DrugBank = 
| ChemSpiderID_Ref = 
| ChemSpiderID = 4941168
| UNII = Y3YKO9X8N8
| KEGG = 
| ChEBI = 
| ChEMBL = 2110968
| synonyms = Pinoxepine; P-5227

<!--Chemical data-->
| C=23 | H=27 | Cl=1 | N=2 | O=2
| molecular_weight = 398.931 g/mol
| SMILES = C1CN(CCN1CC/C=C\2/C3=CC=CC=C3COC4=C2C=C(C=C4)Cl)CCO
| StdInChI_Ref = 
| StdInChI = 1S/C23H27ClN2O2/c24-19-7-8-23-22(16-19)21(20-5-2-1-4-18(20)17-28-23)6-3-9-25-10-12-26(13-11-25)14-15-27/h1-2,4-8,16,27H,3,9-15,17H2/b21-6-
| StdInChIKey_Ref = 
| StdInChIKey = RAAHIUIRJUOMAU-MPUCSWFWSA-N
}}

'''Pinoxepin''' ({{abbrlink|INN|International Nonproprietary Name}}; developmental code name '''P-5227'''), or '''pinoxepin hydrochloride''' ({{abbrlink|USAN|United States Adopted Name}}), is an [[antipsychotic]] of the [[tricyclic compound|tricyclic]] group with a [[dibenzoxepin]] [[ring system (chemistry)|ring system]] which was developed in the 1960s but was never marketed.<ref name="Elks2014">{{cite book|author=J. Elks|title=The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies|url=https://books.google.com/books?id=0vXTBwAAQBAJ&pg=PA984|date=14 November 2014|publisher=Springer|isbn=978-1-4757-2085-3|pages=984–}}</ref><ref name="AcademicPress1967">{{cite book|title=Annual Reports in Medicinal Chemistry|url=https://books.google.com/books?id=nnVxhG5GLXYC&pg=RA2-PR3|date=1 January 1967|publisher=Academic Press|isbn=978-0-08-058346-4|pages=2–}}</ref><ref name="Gordon2012">{{cite book|author=Maxwell Gordon|title=Psychopharmacological Agents|url=https://books.google.com/books?id=38QOitKplWgC&pg=PA102|date=2 December 2012|publisher=Elsevier Science|isbn=978-0-323-15128-3|pages=102–}}</ref><ref name="Iversen2012">{{cite book|author=Leslie Iversen|title=Handbook of Psychopharmacology: Volume 10: Neoroleptics and Schizophrenia|url=https://books.google.com/books?id=C97OBgAAQBAJ&pg=PT200|date=6 December 2012|publisher=Springer Science & Business Media|isbn=978-1-4613-4042-3|pages=200–}}</ref><ref name="Lajtha2013">{{cite book|author=Abel Lajtha|title=Alterations of Metabolites in the Nervous System|url=https://books.google.com/books?id=dYnSBwAAQBAJ&pg=PA335|date=11 November 2013|publisher=Springer Science & Business Media|isbn=978-1-4757-6740-7|pages=335–}}</ref> It was found in [[clinical trial]]s to have effectiveness in the treatment of [[schizophrenia]] similar to that of [[chlorpromazine]] and [[thioridazine]].<ref name="Iversen2012" /> The drug has marked [[sedative]] effects but causes relatively mild [[extrapyramidal symptom]]s.<ref name="AcademicPress1967" /><ref name="Iversen2012" />

==References==
{{Reflist|2}}


{{Navboxes
| title = [[Pharmacodynamics]]
| titlestyle = background:#ccccff
| list1 = 
{{Acetylcholine receptor modulators}}
{{Adrenergic receptor modulators}}
{{Dopamine receptor modulators}}
{{Histamine receptor modulators}}
{{Serotonin receptor modulators}}
}}
{{Tricyclics}}

[[Category:Alcohols]]
[[Category:Antipsychotics]]
[[Category:Chloroarenes]]
[[Category:Dibenzoxepins]]
[[Category:Piperazines]]


{{Nervous-system-drug-stub}}